Research suggests that hyperinsulinemia may contribute to cancer development and progression through several mechanisms. Insulin is a growth factor that can promote cell proliferation and inhibit apoptosis, which are key processes in cancer development. Additionally, high insulin levels can increase the bioavailability of insulin-like growth factor 1 (IGF-1), a potent mitogen that supports tumor growth. These factors create an environment conducive to cancer cell survival and expansion.
